Table.
Donor Information and Details Regarding Antibody Labeling Protocols
| Eye | Age (y) | Sex | Cause of Death | Labeling Protocol |
|---|---|---|---|---|
| 1 | 72 | F | Endometrial Ca | αSMA/lectin |
| 2 | 72 | F | Endometrial Ca | αSMA/lectin |
| 3 | 46 | M | Angiosarcoma | αSMA/phalloidin |
| 4 | 46 | M | Angiosarcoma | αSMA/phalloidin |
| 5 | 18 | M | Drug overdose | αSMA/phalloidin |
| 6 | 82 | M | Ischemic CVA | αSMA/phalloidin |
| 7 | 55 | F | Renal cell Ca | Lectin |
| 8 | 84 | M | Ischemic CVA | Lectin |
| 9 | 89 | F | Hemorrhagic CVA | Lectin |
| 10 | 89 | F | Hemorrhagic CVA | Lectin |
| 11 | 82 | M | Ischemic CVA | Lectin |
| 12 | 75 | F | Endometrial Ca | Lectin |
| 13 | 75 | F | Endometrial Ca | Lectin |
| 14 | 86 | F | Lung Ca | Lectin |
| 15 | 70 | M | Sepsis | Lectin |
| 16 | 42 | M | Hemorrhagic CVA | Phalloidin |
Eyes 1 and 2; 3 and 4; 9 and 10; and 12 and 13 were left and right eyes from the same donor. Ca, carcinoma; CVA, cerebrovascular accident.